• Order intake dynamics remain very strong, particularly in the OEM businesses
• Strong demand translates into revenue growth; profitability improved significantly
• Full-year EBITDA margin now expected at around 22 percent

“In the first three quarters, we saw particularly strong demand, especially in our OEM businesses, which is now also reflected in our revenue and earnings performance. With a firm focus on our customers’ requirements, we are concentrating our operational efforts on further improving our delivery capabilities and expanding our capacities,” said Dr. Dominic Dorfner, CEO of JENOPTIK AG. “2026 will be a successful year for Jenoptik, as, amongst other things, our EBITDA margin guidance upgrade to around 22 percent at the end of October has shown. We are also very confident about 2027, given our high order backlog,” commented Dr. Prisca Havranek-Kosicek, CFO of JENOPTIK AG.

Revenue growth picks up significantly

The photonics group Jenoptik achieved revenue of 803.8 million euros in the first nine months of 2026, representing an increase of 6.7 percent compared with the same period last year (prior year: 753.2 million euros). Third quarter dynamics were particularly strong, with revenue up by 18.0 percent year-over-year.

The Strategic Business Unit (SBU) Semiconductor & Advanced Manufacturing recorded revenue of 367.4 million euros in the reporting period, 16.7 percent above prior year (314.9 million euros), driven by stronger business with customers in both the lithography and inspection areas of the semiconductor equipment industry.

The SBU Biophotonics generated significantly higher revenues in the defense sector during the reporting period, while the very strong prior-year revenue base could not be reached in the medical technology business, as expected. Consequently, revenue of the SBU Biophotonics of 180.1 million euros was slightly down by 1.1 percent on the prior year’s figure of 182.1 million euros.

The SBU Metrology & Production Solutions recorded revenue of 130.9 million euros in the first nine months (prior year: 139.0 million euros), which was lower across all areas, amongst other things, due to the continuing difficult market situation in the automotive industry.

The SBU Smart Mobility Solutions increased its revenue by 11.8 percent to 105.6 million euros (prior year: 94.4 million euros) driven by a strong performance in almost all regions.

Profitability reaches record level

The Group’s EBITDA improved significantly in the first nine months of 2026 to 178.2 million euros, an increase of 35.2 percent compared with the prior year’s figure of 131.8 million euros. Performance in the reporting period was mainly driven, besides revenue growth, by a very favorable product mix – particularly in the third quarter – and the cost-cutting measures implemented in 2025. Accordingly, the Group’s EBITDA margin improved significantly to 22.2 percent in the reporting period (prior year: 17.5 percent).

Group earnings after tax were up by around 57 percent to 74.0 million euros (prior year: 47.0 million euros). Earnings per share amounted to 1.28 euros (prior year: 0.80 euros).

Order intake remained very strong, particularly in the OEM businesses

The Group’s order intake improved significantly in the first nine months of 2026, rising by 41.4 percent to 1,099.2 million euros (prior year: 777.3 million euros), primarily due to strong momentum in the OEM businesses. Hence, order intake of the SBU Semiconductor & Advanced Manufacturing was up by around 90 percent (including a major order as reported in the first quarter) due to strong demand in both the lithography and inspection businesses.

The SBU Biophotonics also recorded a higher order intake (up by around 11 percent), driven by the medical technology & life sciences sector. It includes, however, a major multi-year medical technology contract in the low double-digit million-euro range in the second quarter.

The Group’s book-to-bill ratio came in at 1.37 during the reporting period (prior year: 1.03). As a result, the order backlog increased to 903.2 million euros (31/12/2025: 590.8 million euros).

Investments amounted to 31.9 million euros and primarily related to technical equipment and machinery. This represents a significant decline compared to prior year’s figure of 58.3 million euros, which still included investments in the new factory in Dresden.

Solid position in terms of finances and balance sheet

Free cash flow before interest and taxes improved to 114.6 million euros in the reporting period (prior year: 84.6 million euros), despite an increase in working capital tied up due to higher demand.

With an equity ratio of 59.0 percent (31/12/2025: 60.2 percent), net debt of 260.1 million euros (31/12/2025: 317.4 million euros) and a leverage ratio (net debt to EBITDA) of 1.1x (31/12/2025: 1.6x), Jenoptik maintained very sound financial and balance sheet ratios.

Full-year EBITDA margin now expected at around 22 percent

Based on the very strong order intake and order backlog, the Executive Board continues to expect to achieve revenue growth of between 5 and 9 percent year-on-year in 2026 (2025: 1,046.0 million euros).

In view of a significantly improved product mix, the Executive Board now expects an EBITDA margin of around 22 percent for the full fiscal year 2026 (previously 20 to 21 percent / 2025: 18.4 percent).

With regard to capital expenditure, following a marked decline in the first nine months, the Executive Board expects this to remain significantly below the prior year’s level of 77.4 million euros for the full year (previously: slight decline). Plans to significantly expand optical production capacity, particularly at the Jena site, remain unchanged.

This forecast is subject to the political and economic conditions not deteriorating. Possible changes to the portfolio are not taken into account in this forecast.

Conference call for journalists, analysts and investors

The CEO and CFO of JENOPTIK AG will hold a conference call with analysts, investors, and journalists (in English) on November 10, 2026 at 11:00 am (CET).

The presentation on the first nine months of 2026, the quarterly statement for January through September 2026, and the press release are available on the Jenoptik website at Investors / Reports and Presentations. Images are available for download in the Jenoptik image database at media.jenoptik.com.